You are here

L2 DIAGNOSTICS LLC

Company Information
Address
37 SEYMOUR RD
NEW HAVEN, CT 06525-1231
United States


https://www.L2Dx.com

Information

UEI: GKA7VH5LFR25

# of Employees: 15


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Preclinical development of the tsetse thrombin inhibitor

    Amount: $98,179.00

    DESCRIPTION (provided by applicant): Thromboembolic disease is a major cause of morbidity and mortality in the developed world. Despite the need for effective therapies for treating and preventing pat ...

    SBIRPhase I2004Department of Health and Human Services National Institutes of Health
  2. Isoaspartyl Modified Tumor Antigens for Vaccination

    Amount: $99,829.00

    DESCRIPTION (provided by applicant): This proposal will take advantage of several unique observations made in understanding the properties of self proteins that regulate the development of autoimmune ...

    SBIRPhase I2004Department of Health and Human Services National Institutes of Health
  3. Therapeutic Activity of a Novel Tick Immunosuppressant

    Amount: $99,728.00

    DESCRIPTION (provided by applicant): The overall objective of this proposal is to evaluate the therapeutic potential of a novel immunosuppressant protein produced by tick salivary glands. Ixodes sca ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
  4. A novel platelet inhibitor from bloodfeeding hookworms

    Amount: $99,383.00

    DESCRIPTION (provided by applicant): Thromboembolic disease is a major cause of morbidity and mortality in the developed world. Because platelets play a critical role in the activation and propagati ...

    STTRPhase I2003Department of Health and Human Services National Institutes of Health
  5. Vaccine therapy of congenital adrenal Hyperplasia

    Amount: $135,039.00

    N/A

    STTRPhase I2003Department of Health and Human Services National Institutes of Health
  6. A Novel Family of Anticoagulants from Ixodes scapularis

    Amount: $138,854.00

    DESCRIPTION (provided by applicant): The overall objective of this proposal is to evaluate the anticoagulant properties of a family of novel tick salivary proteins Ixodes scapularis, the black-legged ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
  7. Vaccination Against West Nile Virus

    Amount: $729,355.00

    DESCRIPTION (provided by applicant): A commercially viable recombinant subunit vaccine to prevent West Nile virus infection is the overall objective of this project. West Nile virus was isolated for ...

    SBIRPhase II2003Department of Health and Human Services National Institutes of Health
  8. Vaccination Against West Nile Virus

    Amount: $0.00

    DESCRIPTION (provided by applicant): A commercially viable recombinant subunit vaccine to prevent West Nile virus infection is the overall objective of this project. West Nile virus was isolated for ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
  9. VACCINATION AGAINST IXODES SCAPULARIS TICK BITES

    Amount: $0.00

    DESCRIPTION (provided by applicant): Lyme disease is a multi-systemic infection caused by the pathogen Borrelia burgdorjeri. The black-legged tick, Ixodes scapularis, is the common vector for B. burgd ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  10. VACCINATION AGAINST IXODES SCAPULARIS TICK BITES

    Amount: $748,024.00

    DESCRIPTION (provided by applicant): Lyme disease is a multi-systemic infection caused by the pathogen Borrelia burgdorjeri. The black-legged tick, Ixodes scapularis, is the common vector for B. burgd ...

    SBIRPhase II2002Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government